Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma

British Journal of Ophthalmology

Volumn 87, Issue 12, 2003, Pages 1492-1496

  Pillunat, L E ^a,b   Larsson, L I ^c  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIGLAUCOMA AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; BRINZOLAMIDE; CLONIDINE; DIPIVEFRINE; DORZOLAMIDE; LATANOPROST; PILOCARPINE;

ADULT; AGED; ARTHRITIS; ARTICLE; BLEPHARITIS; CATARACT; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CONJUNCTIVITIS; CORNEA DISEASE; DRUG EFFICACY; DRUG SAFETY; EYE IRRITATION; FEMALE; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HAIR DISEASE; HEADACHE; HUMAN; HYPEREMIA; HYPERTENSION; INFECTION; INSOMNIA; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; OPEN ANGLE GLAUCOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; SKIN DISEASE; TREATMENT OUTCOME; UVEITIS; VEIN THROMBOSIS; VISUAL ACUITY; VISUAL FIELD DEFECT;

EID: 0346256771     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.12.1492     Document Type: Article

References (23)

1. Thylefors B, Negrel AD, Pararajosegaram R, et al. Global data on blindness. Bull World Health Organ 1995;73:115-21.
2. Uusitalo RJ, Palkama A. Long-term evaluation of timolol. Acta Ophthalmol 1989;67:573-81.
3. Boger WP 3rd, Steinert RF, Puliafito CA, et al. Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma. Am J Ophthalmol 1978;86:8-18.
4. Hartenbaum D. The efficacy of dorzolamide, a topical carbonic anhydrase inhibitor, in combination with timolol in the treatment of patients with open-angle glaucoma and ocular hypertension. Clin Ther 1996;18:460-5.
5. Zimmerman TJ, Canale P. Timolol - further observations. Ophthalmology 1979;86:166-9.
6. Weinreb RN. Compliance with medical treatment in glaucoma. J Glaucoma 1992;1:134-6.
7. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 1995;26:233-6.
8. Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: adherence by the elderly. Am J Public Health 1993;83:711-6.
9. Chrai SS, Makoid MC, Eriksen SP, et al. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J Pharm Sci 1974;63:333-8.
10. Baudouin C. Side effects of antiglaucomatous drugs on the ocular surface. Curr Opin Ophthalmol 1996;7:80-6.
11. Alm A, Stjernschantz J, for the Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening and morning. A comparison with timolol. Ophthalmology 1995;102:1743-52.
12. Camras CB, for the United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States. Ophthalmology 1996;103:138-47.
13. Watson P, Stjernschantz J, for the Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 1996;103:126-37.
14. Mishima HK, Masuda K, Kitazawa Y, et al. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. Arch Ophthalmol 1996;114:929-32.
15. Bucci MG, for the Italian Latanoprost Study Group. Intraocular pressure-lowering effects of latanaprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. J Glaucoma 1999;8:24-30.
16. Emmerich K-H. Comparison of latanoprost monotherapy to dorzolamide combined with timolol in patients with glaucoma and ocular hypertension. A 3-month randomised study. Graefes Arch Clin Exp Ophthalmol 2000;238:19-23.
17. Nordmann J-P, Söderström M, Rouland J-F, et al. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta-adrenergic antagonists. Br J Ophthalmol 2000;84:181-5.
18. Larsson L-I. Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% and timolol gel-forming solution 0.5% in patients with ocular hypertension. Ophthalmology 2001;108:1439-44.
19. Lindén C, Alm A. Prostaglandin analogues in the treatment of glaucoma. Drugs Aging 1999;14:387-98.
20. Camras CB. Prostaglandins. In: Ritch R, Shields MB, Krupin T, eds. The glaucomas: glaucoma therapy. 2nd ed. St Louis: Mosby-Year Book, 1996:1449-61.
21. Konstas AG, Maskaleris G, Gratsonidis S, et al. Compliance and viewpoint of glaucoma patients in Greece. Eye 2000;14:752-6.
22. Stewart WC, Chorak RP, Hunt HH, et al. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol 1993;116:176-81.
23. Kass MA, Meltzer DW, Gordon M, et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol 1986;101:515-23.